Osteoporosis drug Fosamax doubles risk of chronically irregular heartbeatApril 29th, 2008 - 1:55 pm ICT by admin
Washington, Apr 29 (ANI): Using the Osteoporosis drug Fosamax can double the risk of developing the most common kind of chronically irregular heartbeat, warns a new study.
The study, appearing in the April 28 Archives of Internal Medicine, was conducted by researchers from Group Health and the University of Washington.
Lead author Susan Heckbert, MD, PhD, MPH, said that the study is especially working as Fosamax is the most widely used drug treatment for osteoporosis, the disease that thins bone density.
The researchers base their findings on the data gathered after analysing more than 700 female Group Health patients.
The found that women who used the drug, called alendronate in its first generic versions, were twice as likely to develop atrial fibrillation or chronically irregular heartbeat, than women not on the drug.
Having ever used alendronate was associated with an 86 percent higher risk of newly detected atrial fibrillation compared with never having used the drug, said Dr. Heckbert, who is also an affiliate investigator at the Group Health Center for Health Studies.
In many cases, atrial fibrillation has no symptoms, and it isnt necessarily life threatening. But it can cause palpitations, fainting, fatigue, or congestive heart failure.
Atrial fibrillation can also make blood pooland sometimes clotin the atria. When parts of clots break off and leave the atria, they can lead to embolic strokes.
The US Food and Drug Administration (FDA) approved the first generic versions (called alendronate) in February. (ANI)
- Diabetes linked to irregular heartbeat - Apr 23, 2010
- Measuring oxidative stress may help predict atrial fibrillation risk - Apr 05, 2011
- Math model to monitor heartbeat health - Feb 19, 2012
- Arthritis invites higher risk of heart attacks - Mar 09, 2012
- Moderate-to-heavy alcohol intake may increase risk of abnormal heart rhythm - Feb 15, 2011
- Now, a technique to regularise abnormal heartbeats - Sep 09, 2012
- Are erratic heartbeats tied to unexplained strokes? - Feb 03, 2012
- Two new drugs can slash stroke risk - Jan 11, 2011
- Alcohol can trigger dangerous palpitations - Jun 04, 2012
- Yoga reduces irregular heartbeat and anxiety - Apr 04, 2011
- Healthy lifestyles could halve cases of atrial fibrillation - Mar 29, 2011
- Irregular heart beat plus stroke may increase dementia risk - Mar 08, 2011
- Gene variant linked to a form of irregular heartbeat identified - Feb 22, 2010
- Tool predicts death probability from stroke - Feb 11, 2011
- The smart phone as diagnostic tool - Oct 07, 2011
Tags: alendronate, archives of internal medicine, atria, bone density, congestive heart failure, female group, fibrillation, food and drug administration, food and drug administration fda, fosamax, generic versions, group health, health center, health patients, health studies, heart failure, irregular heartbeat, md phd, osteoporosis drug, us food and drug administration